Insider Buy/Sell Details for the Biotechnology Industry — April 2026
Ratio0.0:1
Daily Buy & Sell Volume
Transactions (364)
Monte Rosa Therapeutics, Inc. (GLUE)
Nickson Philip — Chief Business & Legal Officer
Shares
5,845
Price
$17.69
Total Value
$103.41K
Shares Held After
55,000
% of Holdings
9.6%
EXOZYMES INC. (EXOZ)
Korman Tyler Paz — Chief Scientific Officer
Shares
750
Price
$10.53
Total Value
$7.89K
Shares Held After
729,123
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
38
Price
$581.45
Total Value
$22.10K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,482
Price
$580.84
Total Value
$860.81K
Shares Held After
40,551
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,046
Price
$580.07
Total Value
$606.75K
Shares Held After
42,033
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,140
Price
$578.83
Total Value
$659.86K
Shares Held After
43,079
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,815
Price
$577.90
Total Value
$1.05M
Shares Held After
44,219
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,478
Price
$576.69
Total Value
$852.35K
Shares Held After
46,034
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,241
Price
$575.75
Total Value
$714.51K
Shares Held After
47,512
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,260
Price
$575.04
Total Value
$724.54K
Shares Held After
48,753
% of Holdings
2.5%
Pharvaris N.V. (PHVS)
Modig Berndt — Director
Shares
200
Price
$28.41
Total Value
$5.68K
Shares Held After
142,084
% of Holdings
0.1%
Pharvaris N.V. (PHVS)
Modig Berndt — Director
Shares
23,133
Price
$27.74
Total Value
$641.60K
Shares Held After
142,284
% of Holdings
14.0%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
1,800
Price
$15.00
Total Value
$27.00K
Shares Held After
213,867
% of Holdings
0.8%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
8,722
Price
$24.83
Total Value
$216.57K
Shares Held After
245,222
% of Holdings
3.4%
Immunovant, Inc. (IMVT)
Van Tuyl Christopher — Chief Legal Officer
Shares
5,165
Price
$24.83
Total Value
$128.25K
Shares Held After
183,231
% of Holdings
2.7%
EXOZYMES INC. (EXOZ)
Korman Tyler Paz — Chief Scientific Officer
Shares
750
Price
$10.04
Total Value
$7.53K
Shares Held After
729,873
% of Holdings
0.1%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
1,518
Price
$24.83
Total Value
$37.69K
Shares Held After
254,439
% of Holdings
0.6%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
8,614
Price
$24.83
Total Value
$213.89K
Shares Held After
255,957
% of Holdings
3.3%
Adicet Bio, Inc. (ACET)
ORBIMED ADVISORS LLC — 10% Owner
Shares
40,416
Price
$6.52
Total Value
$263.51K
Shares Held After
0
% of Holdings
100.0%
Adicet Bio, Inc. (ACET)
ORBIMED ADVISORS LLC — 10% Owner
Shares
32,523
Price
$6.29
Total Value
$204.57K
Shares Held After
0
% of Holdings
100.0%
Protara Therapeutics, Inc. (TARA)
Zummo Jacqueline — Chief R&D Officer
Shares
1,134
Price
$5.40
Total Value
$6.12K
Shares Held After
94,827
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$585.48
Total Value
$163.93K
Shares Held After
40,513
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
486
Price
$584.47
Total Value
$284.05K
Shares Held After
40,793
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,874
Price
$583.44
Total Value
$1.09M
Shares Held After
41,279
% of Holdings
4.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,166
Price
$582.49
Total Value
$1.26M
Shares Held After
43,153
% of Holdings
4.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,337
Price
$581.72
Total Value
$777.75K
Shares Held After
45,319
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
477
Price
$580.59
Total Value
$276.94K
Shares Held After
46,656
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$579.22
Total Value
$278.03K
Shares Held After
47,133
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$578.08
Total Value
$346.85K
Shares Held After
47,613
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$577.07
Total Value
$323.16K
Shares Held After
48,213
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$575.86
Total Value
$299.45K
Shares Held After
48,773
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$572.12
Total Value
$68.65K
Shares Held After
49,293
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$568.74
Total Value
$204.75K
Shares Held After
49,413
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
15
Price
$566.00
Total Value
$8.49K
Shares Held After
49,773
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
225
Price
$565.38
Total Value
$127.21K
Shares Held After
49,788
% of Holdings
0.4%
Rapport Therapeutics, Inc. (RAPP)
Yeleswaram Krishnaswamy — Chief Development Officer
Shares
360
Price
$34.90
Total Value
$12.56K
Shares Held After
286,516
% of Holdings
0.1%
COMPUGEN LTD (CGEN)
Levine Zurit — SVP, Business Development
Shares
5,375
Price
$2.42
Total Value
$13.01K
Shares Held After
29,375
% of Holdings
15.5%
Whitehawk Therapeutics, Inc. (WHWK)
Lennon David James — Director
Shares
63,945
Price
$3.40
Total Value
$217.41K
Shares Held After
533,122
% of Holdings
10.7%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
37,263
Price
$15.19
Total Value
$566.02K
Shares Held After
2,180,518
% of Holdings
1.7%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
100
Price
$15.48
Total Value
$1.55K
Shares Held After
434,188
% of Holdings
0.0%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
30,841
Price
$14.83
Total Value
$457.37K
Shares Held After
434,288
% of Holdings
6.6%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
17,717
Price
$13.01
Total Value
$230.50K
Shares Held After
213,867
% of Holdings
7.7%
Adicet Bio, Inc. (ACET)
ORBIMED ADVISORS LLC — 10% Owner
Shares
2,400
Price
$6.38
Total Value
$15.31K
Shares Held After
32,523
% of Holdings
6.9%
Adicet Bio, Inc. (ACET)
ORBIMED ADVISORS LLC — 10% Owner
Shares
29,319
Price
$6.53
Total Value
$191.45K
Shares Held After
34,923
% of Holdings
45.6%
COMPUGEN LTD (CGEN)
Levine Zurit — SVP, Business Development
Shares
2,500
Price
$2.30
Total Value
$5.75K
Shares Held After
29,375
% of Holdings
7.8%
Whitehawk Therapeutics, Inc. (WHWK)
Lennon David James — Director
Shares
94,087
Price
$3.43
Total Value
$322.72K
Shares Held After
597,067
% of Holdings
13.6%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$13.56
Total Value
$258.45K
Shares Held After
438,526
% of Holdings
4.2%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
20,000
Price
$40.97
Total Value
$819.40K
Shares Held After
2,231
% of Holdings
90.0%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Borgeson Blake — Director
Shares
30,000
Price
$3.10
Total Value
$93.00K
Shares Held After
6,229,863
% of Holdings
0.5%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Gibson Christopher — Director
Shares
40,000
Price
$3.10
Total Value
$124.00K
Shares Held After
906,556
% of Holdings
4.2%
Showing 1–50 of 364 transactions (page 1 of 8)